Cardiomyocyte-specific deletion of NCLX resulted in severe lethality (87%) within two weeks, due to heart failure; whereas overexpression of NCLX resulted in protection from ischemic heart damage (Luongo et al., 2017). This evidence concerns the gene SLC8B1 and heart failure.